Nagase Viita Launches SOLBIOTE (TM), New Brand of Injectable-grade Saccharide Excipients for Biopharmaceuticals
Comunicato Precedente
Comunicato Successivo
Image1: SOLBIOTE (TM) portfolio; TREHALOSE SG and MALTOSE PH https://cdn.kyodonewsprwire.jp/prwfile/release/M104815/202406031668/_prw_PI1fl_MyQw9rBz.jpg
Nagase Viita has a long history of harnessing the power of nature and an expertise in biotechnology, which led it to be the first to successfully mass produce trehalose utilizing starch and enzymes. It is committed to providing a stable supply of safe, high-quality excipients through its integrated manufacturing from saccharide production to refining.
The company will further pursue the development of new saccharide excipients for the SOLBIOTE (TM) portfolio and its advanced pharmaceutical applications, bringing pharmaceutical solutions for universal health.
Image2: Image of SOLBIOTE (TM) https://cdn.kyodonewsprwire.jp/prwfile/release/M104815/202406031668/_prw_PI2fl_hrz1tewp.jpg
The name SOLBIOTE (TM) comes from "Sol + Bio," developed by the company's Biotechnology and starch, a gift from the sun (Sol meaning the sun in Latin), providing Solutions to Biopharmaceuticals.
For further details, visit: https://group.nagase.com/viita/en/products_solutions/pharmaceutical_ingredients/
View original content:https://www.prnewswire.co.uk/news-releases/nagase-viita-launches-solbiote-tm-new-brand-of-injectable-grade-saccharide-excipients-for-biopharmaceuticals-302168077.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




